✦ LIBER ✦

Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy

✍ Scribed by Dranitsaris, George; Schmitz, Susanne; Broom, Reuben J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Small Molecule Targeted Therapies for th

✍ Dranitsaris, G.; Schmitz, S.; Broom, R.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Sunitinib and bevacizumab for first-line

✍ Thompson Coon, J S; Liu, Z; Hoyle, M; Rogers, G; Green, C; Moxham, T; Welch, K; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Economic evaluation of new targeted ther

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

PCN10 Targeted Therapy (TT) for First Li

✍ Matheus, W.; Duran, M.A.; Clark, O.A.C.; Kumar, A.; Ferreira, U.; Botrel, T.E.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN30 A COST—UTILITY ANALYSIS MODEL FOR

✍ I Contreras-Hernandez; J Mould-Quevedo; G Salinas-Escudero; J Tapia-Valencia; G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PCN11 GEFITINIB COMPARED WITH DOUBLET CH

✍ SJ Edwards; N Welton; J Borrill 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB